ASHP Statement on Recent Shootings in Texas, Ohio, and California

Published: August 6, 2019

ASHP (the American Society of Health-System Pharmacists) expresses its deep sense of sadness and grief in light of the recent mass shootings in El Paso, Texas and Dayton, Ohio, where at least 31 innocent people were killed. These senseless acts of violence followed another shooting in Gilroy, California, where 3 people were killed on July 28. 

“Our thoughts and prayers are with those killed and wounded and all of the loved ones they left behind.” said ASHP CEO, Paul W. Abramowitz.  “We thank all of the first responders who immediately put themselves in harm’s way to protect and care for others, as well as all of the healthcare providers who treated and cared for the wounded.”

ASHP and our 50,000 members are committed to doing everything we can to help address violence of all causes, and support the important work of our colleagues at the American Hospital Association through their Hospitals against Violence initiative.

ASHP is planning a special session with more than 100 member leaders during ASHP Policy Week in September to explore additional roles ASHP and hospital and health-system pharmacists can play in helping to prevent gun-related injury and death, and other causes of violence.  Pharmacists are vital members of the healthcare team who are dedicated to the preservation of life, and are committed to working toward a goal of ending all forms of violence.


Posted August 6, 2019

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information